Julie Jordan
CIK 1968554 · Chief Medical Officer · last filed 2026-03-30
Julie Jordan is a Chief Medical Officer who has filed 6 SEC Form 4 insider transactions across 2 companies since 2023. The most recent filing shows the insider sold $18.1K of NGNE on Mar 30, 2026. Across all open-market trades the lifetime net is −$20.8K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $362.9K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$362.9K
2
6
-$20.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NGNE | Chief Medical Officer | 12,472 | $29.10 | $362.9K | -$18.1K | 4 | 2026-03-30 |
| Q32 Bio Inc. (FIXX) Delisted | Chief Medical Officer | 7,496 | $16.82 | $126.1K | -$2.7K | 2 | 2023-08-07 |
Recent Filings
6 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-30 | NGNE | Sell (S) | −828 | -$18.1K | EDGAR |
| 2026-02-24 | NGNE | Grant (A) | +4,900 | $0 | EDGAR |
| 2025-03-28 | NGNE | Grant (A) | +8,400 | $0 | EDGAR |
| 2024-01-18 | NGNE | Grant (A) | — | $0 | EDGAR |
| 2023-08-07 | Q32 Bio Inc. (FIXX) Delisted | Mixed | +4,726 | -$2.6K | EDGAR |
| 2023-08-04 | Q32 Bio Inc. (FIXX) Delisted | Mixed | +251 | -$130 | EDGAR |